Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMGN Amgen

Market Closed 11-15 16:00:00 EST

283.61

-12.32

-4.16%

盘后283.61

+0.000.00%

19:59 EST

High291.50	Low279.62	Vol5.33M
Open291.50	D1 Closing295.93	Amplitude4.01%
Mkt Cap152.45B	Tradable Cap152.03B	Total Shares537.53M
T/O1.51B	T/O Rate0.99%	Tradable Shares536.04M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"Amgen","latestPrice":283.61,"timestamp":1731704400000,"preClose":295.93,"halted":0,"volume":5325131,"hourTrading":{"tag":"盘后","latestPrice":283.61,"preClose":283.61,"latestTime":"19:59 EST","volume":322277,"amount":91398045.6838,"timestamp":1731718779243},"delay":0,"floatShares":536041983,"shares":537532723,"eps":7.832929,"marketStatus":"Market Closed","change":-12.32,"latestTime":"11-15 16:00:00 EST","open":291.5,"high":291.5,"low":279.62,"amount":1508185199.3593,"amplitude":0.040145,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.832929,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":295.93,"dividendRate":0.031311,"preHourTrading":{"tag":"盘前","latestPrice":291.27,"preClose":295.93,"latestTime":"09:29 EST","volume":1658,"amount":485561.2168,"timestamp":1731680999983},"postHourTrading":{"tag":"盘后","latestPrice":283.61,"preClose":283.61,"latestTime":"19:59 EST","volume":322277,"amount":91398045.6838,"timestamp":1731718779243},"volumeRatio":1.450447284992158,"impliedVol":0.5564,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/AMGN","defaultTab":"news","newsList":[{"id":"2483251974","title":"The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2483251974","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483251974?lang=en_us&edition=fundamental","pubTime":"2024-11-16 22:00","pubTimestamp":1731765632,"startTime":"0","endTime":"0","summary":"The recent volatility in key GLP-1 stocks has put the spotlight on the anxiety Wall Street has about the weight loss market. The market is huge — a potential $150 billion a year by the end of the decade — and any financial miss, or negative data of any kind, will trigger outsized sell-offs.This past week, for example, Amgen  lost $12 billion in market value. Hims & Hers  lost 10% in a single day in October when the FDA ended the shortage designation of Eli Lilly's  drugs. . Last month was the most dramatic, when Lilly saw more than $127 billion in stock value wiped out at peak loss in a single day. The company missed analyst estimates on its diabetes and weight-loss drugs, Mounjaro and Zepbound. .The move seen in Lilly's stock is typically reserved for Magnificent Seven stocks. For example, the day after the election, Tesla's  market cap increased by $120 billion.Lilly is one of two market leaders in the space, along with Novo Nordisk , and could be the first $1 trillion","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MLPptlhfYdH29LbgLQOKEQ--~B/aD00NDgxO3c9NzEzNTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/9fb131b0-a2f2-11ef-a6bc-956076f696c8","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MLPptlhfYdH29LbgLQOKEQ--~B/aD00NDgxO3c9NzEzNTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2024-10/9fb131b0-a2f2-11ef-a6bc-956076f696c8"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/the-weight-loss-frenzy-is-making-some-pharma-stocks-much-more-volatile-will-the-drama-continue-140032355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","LU1066053197.SGD","LU1548497426.USD","AMGN","LU0456855351.SGD","LU0265550946.USD","LLY","LU1791710400.SGD","TSLA","LU0006306889.USD","AMZN","LU1691799644.USD","NVO","LU1989764664.SGD","LU0082616367.USD","LU0096364046.USD","BK4524","LU2063271972.USD","LU0353189680.USD","LU1127390331.HKD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU1935042488.USD","LU0348723411.USD","LU0149725797.USD","LU1989764748.USD","LU0072462426.USD","LU2023251221.USD","LU2360032135.SGD","PFE","HIMS","BK4596","LU0127658192.USD","LU0786609619.USD","LU1046421795.USD","LU0107464264.USD","IE00BKPKM429.USD","IE00BK4W5M84.HKD","LU0312595415.SGD","LU1674673691.USD","LU2552382058.USD","BK4548","LU0109392836.USD","LU0158827948.USD","LU2237443382.USD","LU2362540622.SGD","LU1839511570.USD","LU0471298777.SGD","LU1917777945.USD","LU0238689110.USD","LU2417539215.USD"],"gpt_icon":1},{"id":"2483519302","title":"2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=2483519302","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483519302?lang=en_us&edition=fundamental","pubTime":"2024-11-16 20:45","pubTimestamp":1731761100,"startTime":"0","endTime":"0","summary":"Its future is bright, but that doesn't mean it'll always be smooth sailing.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F797556%2Fscientist-examines-samples-with-microscope-while-in-laboratory.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F797556%2Fscientist-examines-samples-with-microscope-while-in-laboratory.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com/investing/2024/11/16/2-reasons-to-buy-amgen-and-1-reason-to-be-cautious/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0289739699.SGD","IE0002141913.USD","SG9999001440.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","LU0058720904.USD","BK4588","AMGN","BK4581","LU0122379950.USD","LU2242646821.SGD","LU1057294990.SGD","LU1023059063.AUD","BK4566","LU1571399168.USD","BK4139","LU0320765992.SGD","BK4534","LU0889565916.HKD","LU0109394709.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4533","LU0868494617.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2242652126.USD"],"gpt_icon":0},{"id":"2483535654","title":"Amgen Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2483535654","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483535654?lang=en_us&edition=fundamental","pubTime":"2024-11-16 05:38","pubTimestamp":1731706680,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 4.16% to $283.61 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.32% to 5,870.62 and Dow Jones Industrial Average  falling 0.70% to 43,444.99.This was the stock's second consecutive day of losses.Amgen Inc. closed $63.24 short of its 52-week high , which the company reached on July 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.40% to $154.00 and Pfizer Inc.  fell 4.69% to $24.80.Trading volume  eclipsed its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"gpt_icon":0},{"id":"2483552729","title":"Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS","url":"https://stock-news.laohu8.com/highlight/detail?id=2483552729","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483552729?lang=en_us&edition=fundamental","pubTime":"2024-11-16 03:30","pubTimestamp":1731699036,"startTime":"0","endTime":"0","summary":"Anna Moneymaker/Getty Images NewsIt's not just vaccine makers that are down following the announcement that former President Donald Trump has nominated Robert F. Kennedy Jr. to be his HHS secretary: Pharma and biotech stocks are also feeling the pinch. That's likely because Kennedy","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180628733/image_2180628733.jpg?io=getty-c-w750","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2180628733/image_2180628733.jpg?io=getty-c-w750"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4296140-large-pharmas-biotechs-down-industries-grapple-with-rfk-jr-hhs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["LU0985481810.HKD","LU1868836914.USD","LU2237443978.SGD","LU0306807586.USD","LU0109391861.USD","HHS","LU0823416689.USD","LU1261432733.SGD","BK4139","LU1983299246.USD","SGXZ99366536.SGD","IE00BBT3K403.USD","LU1551013342.USD","LU0170899867.USD","IE00B19Z3581.USD","SG9999014906.USD","LLY","BK4559","AMGN","LU1894683348.USD","BK4009","LU1868837136.USD","IE00BFTCPJ56.SGD","LU2491050071.SGD","LU1868837300.USD","LU1032466523.USD","LU0708995401.HKD","LU0006306889.USD","SG9999015952.SGD","SG9999018857.SGD","LU0058720904.USD","LU2468319806.SGD","SG9999002224.SGD","PFE","LU2112291526.USD","LU0354030438.USD","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","LU0094547139.USD","LU0061475181.USD","LU1670711123.USD","BK4585","IE00BJT1NW94.SGD","BK4550","LU2237443465.HKD","SG9999001176.SGD","LU1127390331.HKD","BMY","LU2125154778.USD"],"gpt_icon":0},{"id":"2483309140","title":"RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483309140?lang=en_us&edition=fundamental","pubTime":"2024-11-16 00:19","pubTimestamp":1731687540,"startTime":"0","endTime":"0","summary":"Trump's pick for head of HHS is a firm opponent of the new drugs for weight loss and diabetes management. The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr. his pick to head the Department of Health and Human Services.Kennedy is an opponent of GLP-1 drugs, which he has argued are the wrong approach to tackling the obesity crisis. Instead, he has said, the government should promote healthy eating, which would be far less expensive than the drugs, which cost thousands of dollars.Eli Lilly & Co. Inc.  and Denmark's Novo Nordisk  , the two leaders in the GLP-1 space, are pushing to expand insurance coverage for the drugs and have been studying how they achieve benefits beyond weight loss, such as in treating cardiovascular disease and sleep apnea.Kennedy famously blames unhealthy food, unnecessary medicines, including certain vaccines, and fl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0256863902.USD","LU0289739699.SGD","IE0009355771.USD","LU2361044865.SGD","BK4532","SG9999015978.USD","LU2491049909.HKD","LU0122379950.USD","LU0882574139.USD","BK4581","LU1983299246.USD","BK4588","SG9999015952.SGD","LU1804176565.USD","LU2324357040.USD","LU2491050154.USD","LU2237443895.HKD","IE00BFTCPJ56.SGD","IE0004445239.USD","LU0466842654.USD","VKTX","BK4585","BK4534","LU0471298777.SGD","LU2106854487.HKD","LU1868837136.USD","LU2237443549.SGD","IE00BK4W5M84.HKD","LU1974910355.USD","IE0002141913.USD","SRRK","LU0097036916.USD","LU2237443382.USD","LU0820561909.HKD","LU1623119135.USD","LU2361044949.HKD","LU0256863811.USD","AMGN","LU1061106388.HKD","LLY","TERN","GPCR","IE00B2B36J28.USD","SG9999015986.USD","LU2089984988.USD","NVO","SGXZ57979304.SGD","IE00BJLML261.HKD","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2483305981","title":"Amgen, Amazon.Com Inc. Share Losses Lead Dow's 288-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2483305981","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483305981?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:46","pubTimestamp":1731685560,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is declining Friday morning with shares of Amgen and Amazon.com Inc. delivering the stiffest headwinds for the blue-chip average.The Dow  was most recently trading 288 points, or 0.7%, lower, as shares of Amgen  and Amazon.com Inc.  are contributing to the blue-chip gauge's intraday decline.Amgen's shares have dropped $13.99  while those of Amazon.com Inc. have declined $6.20, or 2.9%, combining for an approximately 124-point drag on the Dow.Merck , undefined , and Microsoft  are also contributing significantly to the decline.A $1 move in any one of the 30 components of the benchmark results in a 6.15-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314106906.USD","2NVD.UK","MSFT","NVDA","NVDS.UK","LU0957791311.USD","LU0234572021.USD","LU1935042488.USD","IE00BKPKM429.USD","IE00B7KXQ091.USD","NVD","DJX","DOG","LU2112291526.USD","NVD2.UK","AMGN","NVD3.UK","SNVD.UK","LU1582987324.SGD","3NVD.UK","DXD","LU1951198990.SGD","IE00BZ199S13.USD","LU2430703095.HKD","AMZN","LU0889565833.HKD","SDOW","NVDS","IE00BDRTCR15.USD","LU0289941410.SGD","LU2552382215.SGD","LU0094547139.USD","LU1236620750.USD","LU0203345920.USD","DDM","UDOW","NVDX","NVDD","IE00BFSS7M15.SGD","NVDU","LU1116320737.USD","MRK","LU2433249047.HKD","NVDY","LU2108987350.USD","LU1582987597.SGD",".DJI","IE0034235295.USD","LU0820562030.AUD"],"gpt_icon":1},{"id":"2483308810","title":"BUZZ-Drugmakers extend declines after Trump picks RFK Jr to lead top US health agency","url":"https://stock-news.laohu8.com/highlight/detail?id=2483308810","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483308810?lang=en_us&edition=fundamental","pubTime":"2024-11-15 23:13","pubTimestamp":1731683635,"startTime":"0","endTime":"0","summary":"(Updates)   ** Shares of vaccine makers extend declines after President-elect Donald Trump selected Robert F. Kennedy Jr to lead the Department of Health and Human Services, the United States' top hea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","SGXZ57979304.SGD","LLY","LU0456855351.SGD","LU0320765059.SGD","LU1989771016.USD","IE00BBT3K403.USD","BK4588","NVAX","SG9999002232.USD","LU1623119135.USD","LU1983299246.USD","LU0170899867.USD","SGXZ31699556.SGD","BMY","LU1064131342.USD","MRK","LU0640476718.USD","IE00BN8TJ469.HKD","LU0823416689.USD","LU1917777945.USD","LU1989772840.SGD","IE00B2B36J28.USD","LU1291159041.SGD","SG9999018857.SGD","LU0320765992.SGD","LU0094547139.USD","BK4007","LU1280957306.USD","SGXZ99366536.SGD","LU0306807586.USD","LU0882574139.USD","LU1093756168.USD","PFE","MRNA","SG9999015978.USD","LU1894683264.USD","SG9999014542.SGD","LU1718418525.SGD","LU1868836591.USD","LU0096364046.USD","AMGN","LU1035775433.USD","LU0061475181.USD","LU2237443465.HKD","LU2237443622.USD","SG9999014880.SGD","LU1868836914.USD","LU0417517546.SGD","LU0114720955.EUR"],"gpt_icon":1},{"id":"2483377558","title":"Merck, Amgen Share Losses Lead Dow's 168-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377558","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483377558?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:45","pubTimestamp":1731681900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is trading down Friday morning with shares of Merck and Amgen seeing the biggest declines for the price-weighted average.Shares of Merck  and Amgen  are contributing to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 168 points, or 0.4%, lower.Merck's shares have fallen $3.40  while those of Amgen have dropped $10.23 , combining for a roughly 84-point drag on the Dow.Also contributing significantly to the decline are undefined , undefined , and Microsoft .A $1 move in any one of the 30 components of the Dow equates to a 6.15-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0738911758.USD","NVDU","UDOW","LU0320765059.SGD","DDM","LU2191332357.HKD","LU0640476718.USD","LU1093756168.USD","NVD","NVDD","LU2041044095.USD","LU1280957306.USD","LU1035775433.USD",".DJI","3NVD.UK","BK4503","LU0348723411.USD","LU2077746001.SGD","AMGN","NVDY","SDOW","NVDX","LU1228905540.USD","IE00BK4W5M84.HKD","MSFT","NVDS","NVDA","LU0109392836.USD","LU2023250843.SGD","DXD","MRK","LU2360106780.USD","IE00BJJMRZ35.SGD","NVD2.UK","NVD3.UK","DOG","LU2286300806.USD","NVDS.UK","2NVD.UK","LU1548497426.USD","AMZN","LU0784384876.USD","DJX","LU2250418816.HKD","HK0000320223.HKD","IE00B19Z8X17.USD","LU1941712348.USD","SNVD.UK","BK4141"],"gpt_icon":1},{"id":"2483725703","title":"Shares of Pfizer, Moderna, Eli Lilly, Amgen and Novavax Down Between 2% and 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483725703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483725703?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:36","pubTimestamp":1731681407,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nFWN3MM05A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4501","IE00BFTCPJ56.SGD","LU1023059063.AUD","BK4550","LU1894683264.USD","LU2242646821.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU0456855351.SGD","SG9999011175.SGD","PFE","AMGN","SG9999002232.USD","BK4534","BK4585","LU0868494617.USD","LU0289739699.SGD","IE0009355771.USD","LU0225771236.USD","LU1883839398.USD","LU0109394709.USD","LU0170899867.USD","MRNA","IE00BLSP4452.SGD","LU1061106388.HKD","BK4532","BK4547","LU0985481810.HKD","LU1983299246.USD","BK4548","LU1057294990.SGD","IE00BLSP4239.USD","BK4566","NVAX","SG9999013999.USD","IE000M9KFDE8.USD","BK4007","IE0002141913.USD","LU0306806265.USD","LU1066051498.USD","LU2112291526.USD","SG9999002224.SGD","LU0225284248.USD","LU1066053197.SGD","BK4533","LU2242652126.USD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2483330705","title":"Vaccine Stocks Slide After Trump Nominates Robert F. Kennedy Jr. to Be Top Health Official","url":"https://stock-news.laohu8.com/highlight/detail?id=2483330705","media":"Yahoo Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483330705?lang=en_us&edition=fundamental","pubTime":"2024-11-15 13:40","pubTimestamp":1731649200,"startTime":"0","endTime":"0","summary":"Vaccine stocks slipped on Thursday after multiple reports indicated President-elect Donald Trump would name anti-vaccine activist Robert F. Kennedy Jr. to lead the Department of Health and Human Servi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/moderna-novovax-stocks-slide-after-trump-nominates-robert-f-kennedy-jr-to-be-top-health-official-212802309.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"8b50228a679c44f870e44bbf889089f6","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/moderna-novovax-stocks-slide-after-trump-nominates-robert-f-kennedy-jr-to-be-top-health-official-212802309.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BNTX","LU0170899867.USD","BK4581","PFE","IE00BLSP4452.SGD","LU0306807586.USD","BK4532","LU0321505868.SGD","BK4533","SG9999001176.USD","LU0225284248.USD","BK4585","BK4550","IE00BLSP4239.USD","SG9999002224.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999002232.USD","IE00B19Z3581.USD","BK4592","IE00B19Z3B42.SGD","LU1883839398.USD","LU0321505439.SGD","LU1023059063.AUD","GSK","SG9999001176.SGD","SNY","NVO","IE00BBT3K403.USD","LU0456855351.SGD","BK4548","LU0058720904.USD","BK4551","LU0122379950.USD","BK4501","MRNA","IE0002270589.USD","AMGN","BK4007","SG9999003800.SGD","LU0306806265.USD","LU0234572021.USD","LU0225771236.USD","BK4568","BK4588","LU1894683264.USD","SG9999011175.SGD","NVAX","LU1066051498.USD","BK4547","REGN","LU0289739699.SGD","LU1066053197.SGD","LU0985481810.HKD","LLY","LU1057294990.SGD","BK4534"],"gpt_icon":1},{"id":"2483309233","title":"Amgen initiated with a Peer Perform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2483309233","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483309233?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:16","pubTimestamp":1731619002,"startTime":"0","endTime":"0","summary":"Wolfe Research initiated coverage of Amgen (AMGN) with a Peer Perform rating. Published first on TheFly – the ultimate source for real-time, market...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-initiated-with-a-peer-perform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-initiated-with-a-peer-perform-at-wolfe-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242652126.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","AMGN","LU0058720904.USD","LU2242646821.SGD","BK4581","LU1057294990.SGD","BK4585","LU0868494617.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU0109394709.USD","IE0009355771.USD","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","BK4139","BK4534","LU0889565916.HKD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1061106388.HKD","BK4566","BK4533","BK4588","IE00BFTCPJ56.SGD","LU0289739699.SGD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2483330110","title":"Amgen’s Uplizna shows potential efficacy in rare inflammatory diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2483330110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483330110?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:12","pubTimestamp":1731618760,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgens-uplizna-shows-potential-efficacy-in-rare-inflammatory-diseases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgens-uplizna-shows-potential-efficacy-in-rare-inflammatory-diseases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","BK4585","LU0889565916.HKD","LU2242646821.SGD","LU1023059063.AUD","LU1057294990.SGD","BK4534","LU1061106388.HKD","LU0122379950.USD","BK4139","IE0009355771.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2112291526.USD","LU2242652126.USD","LU0320765992.SGD","AMGN","BK4581","BK4533","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","SG9999001440.SGD","LU1983299246.USD","BK4588","LU0868494617.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2483324583","title":"Amgen Presents New Data Across Rare Inflammatory Diseases at Acr 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483324583","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483324583?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:00","pubTimestamp":1731618008,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nTUA43PMPC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMGN","LU0058720904.USD","LU1023059063.AUD","BK4534","LU1061106388.HKD","BK4566","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4533","LU1983299246.USD","IE00BFTCPJ56.SGD","BK4139","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE0002141913.USD","BK4585","LU2242652126.USD","LU1571399168.USD","BK4581","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","LU0122379950.USD","LU2242646821.SGD","LU0109394709.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2483332212","title":"AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332212","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483332212?lang=en_us&edition=fundamental","pubTime":"2024-11-15 05:00","pubTimestamp":1731618000,"startTime":"0","endTime":"0","summary":"MITIGATE Phase 3 Study Results Reinforce Promise of UPLIZNA asthe First Potential Treatment tor IgG4-RD. Phase 4 AGILE Data Support Shortening KRYSTEXXA Infusion Time. THOUSAND OAKS, Calif., Nov. 14, 2024 /PRNewswire/ -- Amgen  today announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of Rheumatology  Convergence 2024 conference in Washington, D.C., Nov. 14-19, 2024. New data showcase reduction in disease activityby UPLIZNA  in Immunoglobulin G4-Related Disease  and support shorter infusion times for KRYSTEXXA co-administered with weekly oral methotrexate 15 mg.\"These data add to the growing body of evidence for UPLIZNA and KRYSTEXXA and strengthen our commitment to developing new treatment options for rare diseases like IgG4-RD and uncontrolled gout,\" said Jay Bradner, M.D., executive vice president of Research and Development and chief scientific officer at Amgen. \"Patients living with these debilitating conditions dese","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fXOCbBYEhALvuJbXuwlWEQ--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a085ee332e8e3e11ca5c7e5584018b12","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fXOCbBYEhALvuJbXuwlWEQ--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/a085ee332e8e3e11ca5c7e5584018b12"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-presents-data-across-rare-210000210.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-presents-data-across-rare-210000210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2242652126.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","BK4110","AMGN","LU0058720904.USD","LU2242646821.SGD","PML","BK4581","LU1057294990.SGD","BK4585","LU0868494617.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","IE00B2B36J28.USD","IE0002141913.USD","IE0009355771.USD","LU0109394709.USD","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","BK4139","BK4534","LU0889565916.HKD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1061106388.HKD","BK4566","BK4533","BK4588","IE00BFTCPJ56.SGD","RARE","LU0289739699.SGD","ACR","SG9999001440.SGD"],"gpt_icon":0},{"id":"2483538513","title":"Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538513","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483538513?lang=en_us&edition=fundamental","pubTime":"2024-11-15 04:00","pubTimestamp":1731614400,"startTime":"0","endTime":"0","summary":"Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density.Amgen's stock has risen 4.6% this year against a decrease of 3.8% for the pharmaceuticals industry.Amgen AMGN, in a press release, dismissed recent concerns that its obesity candidate, MariTide, may cause loss of bone mineral density . Some analysts at a global financial services firmclaimed that a review of phase I data on MariTide showed that the candidate led to a drop in BMD, which is a measure of the amount of minerals in bones. Reduced BMD can increase the risk of fractures. The data from the phase I study were published in a journal in February. The concerns resulted in a sharp decline in the stock price on Tuesday.Amgen, in the latest press release, said there was no connection between the administration of MariTide and BMD changes.The phase I data do not indicate any concerns related to bone safety. The stock recovered on Wednesday after Amgen’s statement.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/c23rHSrGLTeyi6ecjtGakg--~B/aD0zNDY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/c23rHSrGLTeyi6ecjtGakg--~B/aD0zNDY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/88c5b382e5e9e4ea852e01bfc1435a7b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-shrugs-off-bone-density-200000242.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AMGN","SGXZ51526630.SGD","LU0203201768.USD","LU0256863811.USD","SG9999014906.USD","LU0238689110.USD","LU2491050071.SGD","LU1868836914.USD","LU2324357040.USD","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","LLY","LU1057294990.SGD","BK4566","LU0289739699.SGD","LU0058720904.USD","LU1127390331.HKD","LU0354030511.USD","SG9999013999.USD","LU1551013342.USD","SG9999015978.USD","SG9999015986.USD","LU1366192091.USD","LU1280957306.USD","LU2237443549.SGD","LU2468319806.SGD","IE00B1BXHZ80.USD","LU1804176565.USD","LU0154236417.USD","LU2063271972.USD","IE00BJT1NW94.SGD","LU1814569148.SGD","LU0106261372.USD","LU1868837300.USD","LU2237443895.HKD","IE00BFTCPJ56.SGD","VKTX","LU2360106947.USD","NVO","LU2023250504.SGD","LU0385154629.USD","LU0354030438.USD","LU0820561818.USD","LU1064131342.USD","LU2106854487.HKD","LU0471298777.SGD","LU1868836757.USD","LU1023059063.AUD","LU0006306889.USD","LU0122379950.USD"],"gpt_icon":1},{"id":"2483988333","title":"5 Healthcare Stocks to Buy in a Beaten-Up Sector -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2483988333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483988333?lang=en_us&edition=fundamental","pubTime":"2024-11-15 02:53","pubTimestamp":1731610380,"startTime":"0","endTime":"0","summary":"It has been a shaky time for healthcare stocks, but that only presents a buying opportunity.The Health Care Select Sector SPDR Fund, which owns shares of major U.S. health insurers, medical device makers, and drugmakers, has dropped about 7% since hitting a record high in mid-September. Investors have been selling healthcare stocks, buying up more economically-sensitive ones instead, as the Federal Reserve has cut interest rates and the market accounts for the positive economic consequences from Republicans winning the White House and both chambers of Congress.On average, stocks in the fund trade at about 18 times analysts' expected aggregate earnings for the coming 12 months, versus the S&P 500's 22.4 times. In the past decade, they have often traded at just one or two points below the index. When they're in favor with investors, they tend to trade in line with the broader market.Biogen has to share the Alzheimer's market with its partner Eisai and other pharma","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OEF","BK4566","LU0256863902.USD","SG9999003800.SGD","LU0823416689.USD","LU0640476718.USD","LU1093756168.USD","OEX","LU0109391861.USD","SSO","IE0002141913.USD","IE0009355771.USD","LU2468319806.SGD","AMGN","LLY","SG9999018857.SGD","IE00BK4W5M84.HKD","SPXU","LU0114720955.EUR","SGXZ99366536.SGD","LU0106261372.USD","LU2360106947.USD","LU0985481810.HKD","LU1066051498.USD","LU0097036916.USD","LU1868836914.USD","LU1883839398.USD","SG9999011175.SGD","LU1804176565.USD","UPRO","BK4504",".SPX","ESmain","LU0225771236.USD","VOO","IE00BLSP4452.SGD","SPY","LU1023059063.AUD","SDS","SG9999001176.USD","PFE","LU0889565916.HKD","XLV","IVV","IE00BJLML261.HKD","HCSG","SH","SG9999002232.USD","SG9999017495.SGD","BIIB"],"gpt_icon":1},{"id":"2483819963","title":"Dow's 111-Point Drop Led By Losses For Salesforce, Cisco Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2483819963","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483819963?lang=en_us&edition=fundamental","pubTime":"2024-11-15 01:02","pubTimestamp":1731603720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is down Thursday afternoon with shares of Salesforce and Cisco seeing the biggest losses for the index.The Dow  was most recently trading 111 points, or 0.3%, lower, as shares of Salesforce  and Cisco  have contributed to the index's intraday decline.Salesforce's shares have fallen $8.00  while those of Cisco have fallen $1.20, or 2.0%, combining for an approximately 57-point drag on the Dow.IBM , UnitedHealth , and Amgen  are also contributing significantly to the decline.A $1 move in any one of the 30 components of the benchmark results in a 6.15-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled November 14, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","CSCO","IBM","UNH","CRM"],"gpt_icon":1},{"id":"2483385495","title":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, Sonos","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385495","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483385495?lang=en_us&edition=fundamental","pubTime":"2024-11-15 00:17","pubTimestamp":1731601060,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Oklo, Adial Pharma, SonosEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4N3ML1CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","CNH","NVDS","DOCS","ALSN","ACIU","AAL","LU2237443549.SGD","NEM","PZZA","NVD3.UK","COIN","OKLO","VTR","HUT","ADIL","LU0724617625.USD","NVDU","NVDY","CSCO","HROW","TPR","AAP","AMGN","MA","ZETA","NVD","NVDA","LU0082616367.USD","BW","RIOT","HLT","NVDS.UK","GWH","AESI","SNVD.UK","MARA","NVDD","CPB","NVD2.UK","SONO","PTCT","2NVD.UK","DIS","HIMS","3NVD.UK","NVDL","LU0154245673.USD","NVDX"],"gpt_icon":1},{"id":"2483807851","title":"Citi initiates coverage on 5 new biotech stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2483807851","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483807851?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:54","pubTimestamp":1731596084,"startTime":"0","endTime":"0","summary":"Investing.com -- Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen , Biogen , Gilead , Regeneron , and Vertex .The firm initiated coverage on Gilead and Vertex with Buy ratings, citing solid growth drivers, while Amgen, Biogen, and Regeneron received Neutral ratings due to certain market challenges and pipeline uncertainties.For Amgen, Citi analysts underscore the potential of its obesity and diabetes drug, MariTide, though the firm remains cautious due to competitive pressures in the GLP-1 market.They believe the company’s growth outlook “hinges on MariTide clinical success and to a lesser degree, the trajectory for a number of newer products,” such as Tepezza, Uplizna, Krystexxa, and Imdelltra.“Given consistent growth in CF, with multiple PDUFA dates in early 2025 and a clear path to broader diversification, we are very positive on the growth story for Vertex,” analysts led by Geoff Meacham wrote.Meanwhile, Biogen’s Neutral r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/citi-initiates-coverage-5-biotech-145444148.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2468319806.SGD","IE00B894F039.SGD","LU0289739699.SGD","SQQQ","LU2242646821.SGD","LU0079474960.USD","IE00B19Z3B42.SGD","LU0882574055.USD","QID","LU2456880835.USD","PSQ","LU0122379950.USD","LU0868494617.USD","IE00BKVL7J92.USD","LU0823416689.USD","LU0889565916.HKD","BK4566","GILD","LU0109394709.USD","LU1069344957.HKD","LU1917777945.USD","VERX","LU2417539215.USD","IE00B19Z9P08.USD","VRTX","IE0002270589.USD","QLD","BK4550","LU2242652126.USD","BIIB","BK4023","IE0002141913.USD","LU2023250504.SGD","LU0320765992.SGD","MNQmain","LU2087621335.USD","NQmain","LU2462157665.USD","AMGN","LU1057294990.SGD","REGN","TQQQ","LU2362541273.HKD","LU1093756168.USD","LU2362541513.USD",".IXIC","LU2362540622.SGD","LU1839511570.USD","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2483806254","title":"BUZZ-Citi starts coverage on Amgen with 'neutral' on caution over obesity drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483806254?lang=en_us&edition=fundamental","pubTime":"2024-11-14 22:17","pubTimestamp":1731593861,"startTime":"0","endTime":"0","summary":"** Citi Research starts coverage on Amgen    with a \"neutral\" rating, citing risks to co's experimental weight-loss drug, MariTide, due to intense competition   ** Brokerage sets a PT of $335, representing an ~11% upside to stock's last closing price    ** Citi says Clinical risk for MariTide is high as the bar for weight reduction keeps getting higher, following data for existing obesity drugs from Eli Lilly    and Novo Nordisk  as well as other promising candidates    ** MariTide's potential monthly-dosing frequency would be \"nice to have\" but doctors may prefer obesity drugs that also cover conditions like sleep apnea and others, and AMGN's drug is currently way behind Lilly's drug on that - Citi   ** On Wednesday, AMGN denied links between MariTide and bone density changes, following a 7% drop in its stock on Tuesday       ** Analysts on average rate AMGN shares \"buy\"; median PT is $344 — LSEG data   ** As of last close, AMGN up 4.6% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.1281},{"period":"1month","weight":-0.1182},{"period":"3month","weight":-0.1177},{"period":"6month","weight":-0.0924},{"period":"1year","weight":0.0543},{"period":"ytd","weight":-0.0153}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.","yearOnYearQuotes":[{"month":1,"riseRate":0.634146,"avgChangeRate":0.032606},{"month":2,"riseRate":0.463415,"avgChangeRate":-0.003118},{"month":3,"riseRate":0.512195,"avgChangeRate":0.019417},{"month":4,"riseRate":0.463415,"avgChangeRate":-0.001307},{"month":5,"riseRate":0.536585,"avgChangeRate":0.024998},{"month":6,"riseRate":0.512195,"avgChangeRate":0.004729},{"month":7,"riseRate":0.761905,"avgChangeRate":0.052458},{"month":8,"riseRate":0.619048,"avgChangeRate":0.005154},{"month":9,"riseRate":0.52381,"avgChangeRate":0.002807},{"month":10,"riseRate":0.52381,"avgChangeRate":0.020682},{"month":11,"riseRate":0.619048,"avgChangeRate":0.019183},{"month":12,"riseRate":0.658537,"avgChangeRate":0.050861}],"exchange":"NASDAQ","name":"Amgen","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amgen,AMGN,Amgen股票,Amgen股票老虎,Amgen股票老虎国际,Amgen行情,Amgen股票行情,Amgen股价,Amgen股市,Amgen股票价格,Amgen股票交易,Amgen股票购买,Amgen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction